India’s Precision Medicine: A Vision Hindered by Biobank Regulations
Precision medicine, a transformative approach to healthcare, is redefining the landscape of disease diagnosis and treatment. From groundbreaking personalised healthcare solutions to innovations like mRNA vaccines and gene-editing technologies, the field promises a new era in medical science. Yet, as India stands on the cusp of this revolution, a significant hurdle looms: the lack of robust biobank regulations.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent analysis by The Hindu, India’s inconsistent biobank regulations threaten public trust and impede progress.
The Promise of Precision Medicine
In recent years, precision medicine has witnessed remarkable achievements. Through gene therapy, researchers have restored vision in individuals with genetic mutations, while in the U.K., scientists have reversed diabetes using reengineered stem cells. The rapid development of COVID-19 vaccines using the mRNA platform, which earned a Nobel Prize, further underscores the potential of precision medicine.
India’s Growing Market
The Indian precision medicine market is burgeoning, with projections estimating a value exceeding $5 billion by 2030. Initiatives like the BioE3 policy and the approval of NexCAR19, a domestically developed CAR-T cell therapy, mark significant strides. However, the true potential of these advancements lies in aligning biobank regulations with international standards.
The Biobank Conundrum
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the ICMR guidelines illustrate, participants often consent to provide samples without clarity on data usage, raising concerns about privacy and potential discrimination.
A Path Forward
To harness the full potential of precision medicine, India must establish stringent biobank regulations. Aligning with global standards will not only bolster public trust but also position India as a leader in next-generation therapeutics. As part of international groups like the Quad and BRICS, India has the opportunity to expand its pharmaceutical leadership and enhance its soft diplomatic efforts.
Manjeera Gowravaram, a PhD in RNA biochemistry, provides insightful analysis on the intersection of science and policy.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Artificial intelligence is accelerating across the real estate industry, bringing new productivity platforms, smarter MLS systems, cleaner data tools, and AI‑powered consumer guidance. From United Real Estate’s BullseyeAI assistant to Zillow’s integration with Google NotebookLM and major MLS restructures, technology is rapidly reshaping how agents research properties, communicate with clients, and manage daily workflows. For future and current professionals, understanding these tools isn’t optional—it's becoming the new foundation for a competitive real estate career.
A sweeping Treasury Department rule has activated the first nationwide anti–money laundering requirements for residential real estate, forcing professionals involved in closings and settlements to report certain non‑financed property transfers. The move closes long‑standing loopholes that allowed criminals, corrupt officials, and foreign adversaries to hide illicit funds in U.S. housing. Backed by recent federal court decisions, the rule positions the U.S. as a global leader in financial transparency—and signals that commercial real estate may be next. For today’s real estate professionals, staying compliant is becoming just as essential as understanding the market itself.
United Real Estate has introduced BullseyeAI, a fully integrated AI platform designed to help agents cut overhead, automate daily tasks, and reclaim valuable time. Powered by a proprietary large‑language‑model system, BullseyeAI blends dashboards, navigation, voice commands, and automated assistants into one intelligent workspace. With AI agents like Sofie and Rosie managing client nurturing, recruiting workflows, marketing, data handling, and more, the platform marks a major leap toward faster, smarter productivity for real estate professionals.
Boynton Beach residents are reeling after a new city ordinance began issuing fines to homeowners for parking on their own property—unless the vehicle sits on an official driveway. The rule bans parking on grass or unpaved areas, shocking families who’ve parked the same way for years. With fines starting at 25 dollars per car and rising if unpaid, many residents say the sudden crackdown is unfair and financially burdensome, sparking a heated debate over property rights and local government authority.
From AI assistants like United’s BullseyeAI to MLS upgrades rolling out across the country, real estate professionals are entering a new tech‑driven era. This week’s highlights include smarter productivity tools, unified MLS systems, enhanced data access, and even AI‑powered buyer education through Zillow’s new NotebookLM partnership. Whether you’re a seasoned broker or preparing for your license exam, these innovations show how rapidly the industry is evolving—and why staying informed is becoming essential for success.
Artificial intelligence is rapidly moving from a helpful tool to a central force inside real estate transactions, MLS systems, and agent workflows. As AI reshapes everything from listing photos to data distribution, MLSs, regulators, and brokerages are racing to set clear rules that protect consumers and reduce legal risks. With new laws, updated agreements, and rising debates over who should regulate AI, the industry is confronting a defining moment—one that every current and future real estate professional must understand.
Biobanks, essential repositories of biological samples, are critical to the success of precision medicine. These collections of blood, DNA, and tissue samples, coupled with genetic data, form the backbone of research aimed at developing targeted therapies for diseases like cancer and diabetes. However, as highlighted in a recent 
While countries like the U.K., U.S., and Japan have comprehensive biobank regulations ensuring data protection and privacy, India’s framework remains fragmented. The absence of a single authority to regulate biobanks and the lack of penalties for misconduct create risks of ethical violations and undermine public confidence. As the 
